APR 07, 2016 2:02 PM PDT

New Biomarker for Lung Cancer Detection?

WRITTEN BY: Xuan Pham
Scientists identify new growth factor involved in lung cancer proliferation
Lung cancer is the second most common form of cancer in both men and women. With such a high incidence rate and an equally alarming mortality rate, research in early detection could make a big difference in patients’ outcomes. To that end, researchers at University of Colorado have found a new biomarker, which could be used in diagnostics and detection of lung cancer.
 
Lung cancer is divided into three types: Non-small cell lung cancer, which makes up about 85 percent of cases; small cell lung cancer, which makes up 10-15 percent and has a tendency to metastasize; and, lung carcinoid tumor, which is most rare and slow-growing. Most notably, the risk of developing lung cancer is highly influenced by smoking, with 90 percent of cases due to tobacco use.
 
 
What contributes to lung cancer’s deadliness is its ability to go undetected. In the early stages, most patients are asymptomatic, showing little to no signs of the cancer’s presence. Only after the disease has advanced do patients report symptoms, such as difficulty breathing, blood in mucus, and other respiratory abnormalities. As such, lung cancer is the leading cause of cancer-related death in the US.
 
Two years ago, researchers from the University of Colorado (UC) Cancer Center identified a growth factor protein, known as epiregulin (Ereg) that was linked to two mouse models of lung cancer. What they didn’t know at the time was the extent to which Ereg could be causative in the disease. Their current studies answer this question as well as point to Ereg as a potential new therapeutic target.
 
Led by Rana Brooks, the team used mouse models of lung cancer and tested the effects of Ereg deletion in these mice. They found mice lacking the growth factor Ereg showed reduced inflammation and tumor growth, as compared to normal mice. "Basically, we saw that mice without Ereg developed fewer tumors," said Alison Bauer, Assistant Professor at the UC Cancer Center, and first study author.
 
As the overall tumor burden decreased, the researchers also observed that treatment of recombinant Ereg increased wound healing in both human and mouse lung epithelial cell lines. This piece of evidence suggests Ereg influences abnormal cell proliferation. As such, it can be leveraged to be a powerful early cancer biomarker and target for new therapies.
 
"This is in line with what you would expect from a functional growth factor," said Bauer. "It appears as if Ereg increases cell proliferation, with increased levels of Ereg in cancer cells promoting the growth and proliferation of tumors."

Growth factors have previously been implicated in many types of cancers. Most notably, the epidermal growth factor (EGF) and its receptors (EGFR) were linked to lung cancer, and can be countered with anti-EGFR therapies such as erlotinib and gefitinib. Ereg is an EGF-like growth factor but has largely been under-studied. Finding out the precise mechanism of how it influences inflammation in lung cancer will be the next focus for the team’s work.
 
"This really is new," she says. "And while that presents a challenge in the lack of science surrounding Ereg, it also presents an exciting opportunity to push forward with a promising biomarker that hasn't been described in this context."

Additional source: EurekAlert!
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUN 07, 2021
Health & Medicine
Higher Incidence of Breast Cancer in Polluted Urban Areas
JUN 07, 2021
Higher Incidence of Breast Cancer in Polluted Urban Areas
A Taiwanese study looked at the incidence of breast cancer in areas of Taiwan with varying levels of air pollutants. Air ...
JUN 07, 2021
Cancer
Inflammatory-rich diet associated with greater risk of developing breast cancer
JUN 07, 2021
Inflammatory-rich diet associated with greater risk of developing breast cancer
A breakthrough study soon to be presented at NUTRITION 2021 LIVE ONLINE later this week reports that women who main ...
JUN 12, 2021
Cancer
Using astronomy to image cancer tumors
JUN 12, 2021
Using astronomy to image cancer tumors
In an interdisciplinary breakthrough, a recent study published in Science describes the development of a new platform, d ...
AUG 18, 2021
Cannabis Sciences
Cancer Patients Use Less Cannabis than General Public
AUG 18, 2021
Cancer Patients Use Less Cannabis than General Public
Despite increasing legalization for recreational cannabis across the US, cancer patients have largely abstained from usi ...
OCT 14, 2021
Cancer
Mechanism of Resistance to Colorectal Cancer Treatment Uncovered
OCT 14, 2021
Mechanism of Resistance to Colorectal Cancer Treatment Uncovered
Colorectal cancer develops when a series of changes occur across multiple genes.  While researchers have paid signi ...
OCT 25, 2021
Cell & Molecular Biology
The Labroots 2021 Cell Biology Virtual Event Poster Winner: 5-Azacytidine Treatment & Lung Cancer
OCT 25, 2021
The Labroots 2021 Cell Biology Virtual Event Poster Winner: 5-Azacytidine Treatment & Lung Cancer
Labroots virtual events are a great place to share research and learn about others work. These events feature participan ...
Loading Comments...